|
KIAA0430 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.91199999458547E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.18820000902542E-09 |
| Normal-vs-Stage2 |
4.014300E-02 |
| Normal-vs-Stage3 |
4.117700E-03 |
| Normal-vs-Stage4 |
1.884490E-02 |
| Stage1-vs-Stage2 |
2.479200E-01 |
| Stage1-vs-Stage3 |
4.761400E-01 |
| Stage1-vs-Stage4 |
9.512600E-01 |
| Stage2-vs-Stage3 |
7.046800E-01 |
| Stage2-vs-Stage4 |
4.895200E-01 |
| Stage3-vs-Stage4 |
6.760200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.54759999984699E-07 |
| Normal-vs-AfricanAmerican |
2.02360000001178E-06 |
| Normal-vs-Asian |
8.24350000000473E-05 |
| Caucasian-vs-AfricanAmerican |
5.675800E-01 |
| Caucasian-vs-Asian |
2.845000E-01 |
| AfricanAmerican-vs-Asian |
3.529600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.08070000013083E-09 |
| Normal-vs-Female |
9.736100E-03 |
| Male-vs-Female |
1.802340E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.28479999994546E-06 |
| Normal-vs-Extreme_Weight |
7.43060057928346E-11 |
| Normal-vs-Obese |
1.132340E-02 |
| Normal-vs-Extreme_Obese |
9.500000E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.270000E-01 |
| Normal_Weight-vs-Obese |
2.462400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.840000E-01 |
| Extreme_Weight-vs-Obese |
3.390000E-04 |
| Extreme_Weight-vs-Extreme_Obese |
8.814000E-01 |
| Obese-vs-Extreme_Obese |
1.242040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.955150E-04 |
| Normal-vs-Age(41-60Yrs) |
2.788700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.69749994458368E-09 |
| Normal-vs-Age(81-100Yrs) |
1.38390000004041E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.292000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.180200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.298800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.870000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.292000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.576800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.87959999681442E-08 |
| Normal-VS-Type2 PRCC |
5.13550000302843E-08 |
| Normal-VS-KIRP CIMP |
1.801790E-03 |
| Normal-VS-Unclassified PRCC |
3.972800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.331000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.619600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.220400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.951200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.096200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.332370E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.19170000534297E-08 |
| Normal-vs-N1 |
3.768400E-02 |
| Normal-vs-N2 |
4.385400E-04 |
| N0-vs-N1 |
4.591800E-02 |
| N0-vs-N2 |
6.210200E-01 |
| N1-vs-N2 |
2.223200E-01 |
|
|
